Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer

被引：0
|
作者：
Susan M. Farabaugh
Bonita T. Chan
Xiaojiang Cui
Robert K. Dearth
Adrian V. Lee
机构：
[1] University of Pittsburgh Cancer Institute,Women’s Cancer Research Center, Department of Pharmacology and Chemical Biology
[2] Magee Women’s Research Institute,Lester and Sue Smith Breast Center, Department of Molecular and Cellular Biology
[3] Baylor College of Medicine,undefined
来源：
Cell Communication and Signaling | / 14卷
关键词：
IRS; ErbB2; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The Cause of ErbB2 Receptor Resistance to Downregulation
    Shramova, E. I.
    Proshkina, G. M.
    Deyev, S. M.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2018, 44 (03) : 279 - 288
  • [32] Cerulenin suppresses ErbB2-overexpressing breast cancer by targeting ErbB2/PKM2 pathway
    Lv, Sinan
    Zhang, Yunwu
    Song, Jiawei
    Chen, Jingruo
    Huang, Bohan
    Luo, Yuhan
    Zhao, Yuhua
    MEDICAL ONCOLOGY, 2022, 40 (01)
  • [33] Cerulenin suppresses ErbB2-overexpressing breast cancer by targeting ErbB2/PKM2 pathway
    Sinan Lv
    Yunwu Zhang
    Jiawei Song
    Jingruo Chen
    Bohan Huang
    Yuhan Luo
    Yuhua Zhao
    Medical Oncology, 40
  • [34] Induction of ERBB2 Nuclear Transport after Radiation in Breast Cancer Cells
    罗波
    于世英
    庄亮
    夏曙
    赵臻
    荣磊
    Current Medical Science, 2009, (03) : 350 - 353
  • [35] Induction of ERBB2 Nuclear Transport after Radiation in Breast Cancer Cells
    Luo, Bo
    Yu, Shiying
    Zhuang, Liang
    Xia, Shu
    Zhao, Zhen
    Rong, Lei
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (03) : 350 - 353
  • [36] Bifunctional effect of resveratrol on the expression of ErbB2 in human breast cancer cell
    Choi, Hoo Kyoon
    Yang, Jin Won
    Kang, Keon Wook
    CANCER LETTERS, 2006, 242 (02) : 198 - 206
  • [37] Tucatinib HER2 (ErbB2) inhibitor Treatment of breast and colorectal cancer
    Patil, T.
    Shagisultanova, E.
    Borges, V. F.
    DRUGS OF THE FUTURE, 2019, 44 (01) : 11 - 19
  • [38] Comparative multi-methodological measurement of ERBB2 status in breast cancer
    Ginestier, C
    Charafe-Jauffret, E
    Penault-Llorca, F
    Geneix, JN
    Adélaïde, J
    Chaffanet, M
    Mozziconacci, MJ
    Hassoun, J
    Viens, P
    Birnbaum, D
    Jacquemier, J
    JOURNAL OF PATHOLOGY, 2004, 202 (03): : 286 - 298
  • [39] Induction of ERBB2 nuclear transport after radiation in breast cancer cells
    Bo Luo
    Shiying Yu
    Liang Zhuang
    Shu Xia
    Zhen Zhao
    Lei Rong
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29 : 350 - 353
  • [40] Dual kinase inhibitor for EGFR mutants and ErbB2 limit breast cancer
    Goel, Peeyush N.
    Zhang, Hongtao
    Murali, Ramachandran
    Zheng, Cai
    Ji, Mei Q.
    Patterson, Angelica
    Grover, Payal
    Greene, Mark
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 651 : 39 - 46
12345